Simple Radical Metabolic Pathways for Anti-TB Drug & Others

 

Ｒａｄｉｃａｌ　Ｍｅｔａｂｏｌｉｃ　Ｐａｔｈｗａｙｓ

Ｆｏｒ　Ｉｓｏｎｉａｚｉｄ, Ｄｅｌａｍａｎｉｄ and Ｅｐａｌｒｅｓｔａｔ．

This Paper deals with the new radical metabolic patway
for two ant-TB drugs (Isoniazid and Delamanid) and one
ARI (aldose reductase inhibitor).

http://www.pnas.org/content/100/24/13881.full

Ｐｉｔａｖａｓｔａｔｉｎ　Ｗｏｒｋｓ　Ａｓ　ＲｈｏＡ

 

Ｉｎｖｅｒｓｅ　Ａｇｏｎｉｓｔ　Ｂｕｔ　Ｎｏｔ　ＧＰＣＲ１２０　Ｌｉｇａｎｄ．